BridgeMD
New treatment option for Neonatal Respiratory Distress Syndrome
Official title MINImising Total Radiation EXposure in Preterm Infants
ClinicalTrials.gov ID: NCT06975189
What this study is testing
- What it's testing
- Being born too early (preterm birth) is the leading cause of death in children world-wide. In Australia, 97% of very preterm babies who are admitted to Neonatal Intensive Care Units need breathing support after birth to survive.
- Phase 2: a mid-size study of how well it works
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages up to 24
You may be able to join if
- All infants born \<32 weeks' gestation and admitted to the neonatal intensive care unit (NICU) who require lung imaging for respiratory indications...
- The infant is born from 22 to 31+6 weeks' gestation by best obstetric estimate and admitted to the NICU
- The infant is considered to require lung imaging for respiratory indications
- The infant has a parent/guardian who can provide informed consent.
You likely can't join if
- The infant will only require CXR to be performed solely to confirm device position i.e. central line, endotracheal tube, gastric tubes
- The infant will only require CXR to be performed for specifically for non-respiratory indications i.e. assessment of cardiac silhouette
- The infant's Clinician has concern regarding clinical stability and side effects of ultrasound scans
- The infant's skin integrity will not tolerate ultrasound gel
- Refusal of informed consent by their parent/guardian/legally acceptable representative
- The infant does not have a parent/guardian who can provide informed consent.
The study team makes the final eligibility decision.
Where it's taking place
- Melbourne, Victoria, Australia
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, up to 24 hours. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Melbourne, Victoria, Australia. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.